News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Scientists uncover new genes possibly linked to MS

diciembre 08, 2022

The findings provide promising targets for future therapy research.
Learn more

Study shows cancer treatment may offer useful approach to MS

diciembre 07, 2022

The findings extend the powerful tool of immunotherapy to a class of diseases that are often debilitating and difficult to treat.
Learn more

Multiple sclerosis therapy improves gut flora

diciembre 02, 2022

Treatment with dimethyl fumarate reduced the proportion of proinflammatory types of bacteria, which have been linked to MS, and supported the growth of “good” bacteria.
Learn more

Researchers seek to know why stem cell treatment works

noviembre 14, 2022

These findings have enabled the researchers to understand why stem cell transplants are usually so successful.
Learn more

Study finds obesity linked to poorer disability outcomes

noviembre 04, 2022

The findings suggest that dedicated management of obesity should be explored for its potential merit in improving long-term clinical outcomes of patients diagnosed with MS.
Learn more

Study: Brain discovery may help boost body’s ability to fight MS

octubre 19, 2022

The findings may point to a treatment avenue that could alter the behavior of these native brain cells to behave in a more neuroprotective way.
Learn more

Researchers seek participants to test drug safety

octubre 14, 2022

The study drug combines an antibody with a “brain shuttle” module, which delivers it to the brain.
Learn more

Researchers seek adolescent participants for ocrelizumad trials

octubre 13, 2022

This two-year study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of ocrelizumab in children and adolescents with relapsing-remitting MS.
Learn more

Researchers seeking patients with relapsing MS to participate in a clinical trial

octubre 12, 2022

The FENhance study is assessing how safe and effective the investigational study drug is in treating RMS.
Learn more

Scientists uncover new genes possibly linked to MS

diciembre 08, 2022

The findings provide promising targets for future therapy research.
Learn more

Study shows cancer treatment may offer useful approach to MS

diciembre 07, 2022

The findings extend the powerful tool of immunotherapy to a class of diseases that are often debilitating and difficult to treat.
Learn more

Multiple sclerosis therapy improves gut flora

diciembre 02, 2022

Treatment with dimethyl fumarate reduced the proportion of proinflammatory types of bacteria, which have been linked to MS, and supported the growth of “good” bacteria.
Learn more

Researchers seek to know why stem cell treatment works

noviembre 14, 2022

These findings have enabled the researchers to understand why stem cell transplants are usually so successful.
Learn more

Study finds obesity linked to poorer disability outcomes

noviembre 04, 2022

The findings suggest that dedicated management of obesity should be explored for its potential merit in improving long-term clinical outcomes of patients diagnosed with MS.
Learn more

Study: Brain discovery may help boost body’s ability to fight MS

octubre 19, 2022

The findings may point to a treatment avenue that could alter the behavior of these native brain cells to behave in a more neuroprotective way.
Learn more

Researchers seek participants to test drug safety

octubre 14, 2022

The study drug combines an antibody with a “brain shuttle” module, which delivers it to the brain.
Learn more

Researchers seek adolescent participants for ocrelizumad trials

octubre 13, 2022

This two-year study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of ocrelizumab in children and adolescents with relapsing-remitting MS.
Learn more

Researchers seeking patients with relapsing MS to participate in a clinical trial

octubre 12, 2022

The FENhance study is assessing how safe and effective the investigational study drug is in treating RMS.
Learn more

Researchers seek patients with primary progressive MS for clinical trial

octubre 10, 2022

The FENtripid Study is assessing how safe and effective the investigational study drug is in treating PPMS.
Learn more

Model predicts MS symptom outcomes during stay-at-home periods

octubre 06, 2022

The work could help inform policymakers tasked with issuing future stay-at-home orders or other similar responses during pandemics or natural disasters.
Learn more

Study: Improvements, few side effects with new stem cell treatment 

septiembre 19, 2022

Biomarker analyses showed consistent treatment effects in neuroinflammation and neuroprotection pathways.
Learn more

MS Focus Providing Relief for Disaster Survivors

septiembre 19, 2022

MS Focus has announced that the organization’s Cooling Program is being reopened for those in disaster zones.
Learn more

Healthcare spending may help explain link between MS and latitude

agosto 26, 2022

A new analysis shows the amount a country spends on healthcare may help explain the link between MS and latitude.
Learn more

Monkeypox vaccine and MS

agosto 15, 2022

Jynneos, is a nonreplicating live vaccine and is felt to be safe for all, regardless of immune status.
Learn more

Processing training has sustained benefits for individuals with MS  

mayo 25, 2022

Effective ways to improve processing speed in this population have the potential to enhance outcomes.
Learn more

Findings open way for personalized MS treatment

mayo 23, 2022

Researchers identified four new target molecules of potential significance for future personalised treatment of MS.
Learn more

Study: Interpersonal emotion regulation beneficial for countering depression in MS

mayo 20, 2022

This study, the first to provide Class 1 evidence of IER’s efficacy in the MS population, is an important step in addressing psychological comorbidities.
Learn more


Show More News